Tls Advisors LLC Mei Pharma, Inc. Transaction History

Tls Advisors LLC

  • $47.3 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 15, 2023
SELL
$0.23 - $7.7 $244,948 - $8.2 Million
-1,064,995 Closed
0 $0
Q1 2023

Nov 15, 2023
SELL
$0.21 - $0.35 $198,510 - $330,851
-945,290 Reduced 47.02%
1,064,995 $244,000
Q4 2022

Feb 14, 2023
BUY
$0.22 - $8.4 $442,262 - $16.9 Million
2,010,285 New
2,010,285 $490,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $314M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Tls Advisors LLC Portfolio

Follow Tls Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tls Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tls Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email